Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;24(3):413-415.
doi: 10.1007/s10456-021-09790-w. Epub 2021 Jun 8.

Letter in response to: circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality

Affiliations
Comment

Letter in response to: circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality

P Bhogal et al. Angiogenesis. 2021 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

PB has previously approached both Sanofi to trial Caplacizumab and Lees pharma to trial Anfibatide in COVID + ve patients. GC, GP, and OJ none relevant.

Comment on

References

    1. Philippe A, Chocron R, Gendron N, Bory O, Beauvais A, Peron N, et al. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021;15:1–13. - PMC - PubMed
    1. Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;15(190):62. doi: 10.1016/j.thromres.2020.04.014. - DOI - PMC - PubMed
    1. Goshua G, Pine AB, Meizlish ML, Chang C-H, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–e582. doi: 10.1016/S2352-3026(20)30216-7. - DOI - PMC - PubMed
    1. Rauch A, Labreuche J, Lassalle F, Goutay J, Caplan M, Charbonnier L, et al. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19. J Thromb Haemost JTH. 2020;18(11):2942–2953. doi: 10.1111/jth.15067. - DOI - PMC - PubMed
    1. Ladikou EE, Sivaloganathan H, Milne KM, Arter WE, Ramasamy R, Saad R, et al. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19? Clin Med Lond Engl. 2020;20(5):e178–e182. doi: 10.7861/clinmed.2020-0346. - DOI - PMC - PubMed

Substances